Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy

Leuk Res. 2021 Oct:109:106640. doi: 10.1016/j.leukres.2021.106640. Epub 2021 Jun 10.

¹ Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
² Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
³ Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
⁴ Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
⁵ Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: Eric.Padron@moffitt.org.

No abstract available

Keywords: CMML; Cytoreductive therapy; MDS/MPN overlap syndrome; MPN.

Publication types